Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DeveloGen builds out

The merger of DeveloGen AG, a functional genomics company, with HepaVec AG, focused on gene delivery, provides a model for the numerous small European biotechs that have emerged with interesting but incomplete technology platforms. The deal, to be accomplished though a stock swap, will give DeveloGen access to

Read the full 489 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers